Lung injury in Preterm Neonates: The role and therapeutic potential of stem cells

Antioxidants and Redox Signaling

Volumn 17, Issue 7, 2012, Pages 1013-1040

  Alphonse, Rajesh S ^a   Rajabali, Saima ^a   Thébaud, Bernard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT;

AMNION CELL; ARTIFICIAL VENTILATION; CELL FUNCTION; CELL THERAPY; CHRONIC LUNG DISEASE; CYTOLOGY; DISEASE SEVERITY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG GAS EXCHANGE; LUNG INJURY; MESENCHYMAL STEM CELL; MORBIDITY; NEWBORN; OXIDATIVE STRESS; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; PERINATAL CARE; PREMATURITY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG INJURY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STEM CELL TRANSPLANTATION;

EID: 84864588880     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4267     Document Type: Review

References (268)

1. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis". Am J Respir Crit Care Med 164: 1755-1756, 2001.
2. Adamson IY and Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest 30: 35-42, 1974.
3. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, and Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749-L758, 2003. (Pubitemid 36459020)
4. Agostini C. Stem cell therapy for chronic lung diseases: hope and reality. Respir Med 104 Suppl 1: S86-S91, 2010.
5. Aguilar S, Scotton CJ, McNulty K, Nye E, Stamp G, Laurent G, Bonnet D, and Janes SM. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 4: e8013, 2009.
6. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 159: 945-958, 1999. (Pubitemid 29137801)
7. Allison BJ, Crossley KJ, Flecknoe SJ, Davis PG, Morley CJ, Harding R, and Hooper SB. Ventilation of the very immature lung in utero induces injury and BPD-like changes in lung structure in fetal sheep. Pediatr Res 64: 387-392, 2008.
8. Alphonse R, Vadivel A, Waszak P, Coltan L, Fung M, Eaton F, Yoder MC, and Thébaud B. Existence, functional impairment and therapeutic potential of endothelial colony forming cells (ECFCs) in oxygen-induced arrested alveolar growth. Am J Respir Crit Care Med 183: A1237, 2011.
9. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, and Cataltepe S. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173: 318-326, 2006. (Pubitemid 43209087)
10. Ambalavanan N and Novak ZE. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res 53: 240-244, 2003. (Pubitemid 36177119)
11. Asikainen TM and White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6: 155-167, 2004. (Pubitemid 38063987)
12. Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, Hascoet JM, Hibbs AM, Kinsella JP, Mercier JC, Rich W, Schreiber MD, Wongsiridej PS, Subhedar NV, Van Meurs KP, Voysey M, Barrington K, Ehrenkranz RA, and Finer NN. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics 128: 729-739, 2011.
13. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, and Tarnow-Mordi W. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 11: 6, 2011.
14. Askie LM, Henderson-Smart DJ, Irwig L, and Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349: 959-967, 2003. (Pubitemid 37064769)
15. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, and Kourembanas S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130, 2009.
16. Auten RL and Davis JM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 66: 121-127, 2009.
17. Auten RL, Whorton MH, and Nicholas Mason S. Blocking neutrophil influx reduces DNA damage in hyperoxiaexposed newborn rat lung. Am J Respir Cell Mol Biol 26: 391-397, 2002. (Pubitemid 34253922)
18. Baber SR, Deng W, Master RG, Bunnell BA, Taylor BK, Murthy SN, Hyman AL, and Kadowitz PJ. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol 292: H1120-H1128, 2007.
19. Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, and Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 180: 454-461, 2009.
20. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, and Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292: L1073-L1084, 2007. (Pubitemid 47084852)
21. Balasubramaniam V, Ryan SL, Seedorf GJ, Roth EV, Heumann TR, Yoder MC, Ingram DA, Hogan CJ, Markham NE, and Abman SH. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol 298: L315-L323, 2010.
22. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, and Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L964-L971, 2003. (Pubitemid 36687131)
23. Ballard PL, Truog WE, Merrill JD, Gow A, Posencheg M, Golombek SG, Parton LA, Luan X, Cnaan A, and Ballard RA. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics 121: 555-561, 2008.
24. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, and Coburn CE. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355: 343-353, 2006. (Pubitemid 44127537)
25. Baraldi E, Carraro S, and Filippone M. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum Dev 85: S1-S3, 2009.
26. Baydas G, Karatas F, Gursu MF, Bozkurt HA, Ilhan N, Yasar A, and Canatan H. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res 33: 276-280, 2002. (Pubitemid 34553355)
27. Belteki G, Kempster SL, Forhead AJ, Giussani DA, Fowden AL, Curley A, Charnock-Jones DS, and Smith GC. Paraoxonase-3, a putative circulating antioxidant, is systemically up-regulated in late gestation in the fetal rat, sheep, and human. J Clin Endocrinol Metab 95: 3798-3805, 2010.
28. Berger AC, Tang G, Alexander HR, and Libutti SK. Endothelial monocyte-activating polypeptide II, a tumorderived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. J Immunother 23: 519-527, 2000.
29. Berger TM, Frei B, Rifai N, Avery ME, Suh J, Yoder BA, and Coalson JJ. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 43: 719-726, 1998. (Pubitemid 28243640)
30. Bertoncello I and McQualter JL. Endogenous lung stem cells: what is their potential for use in regenerative medicine? Expert Rev Respir Med 4: 349-362, 2010.
31. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001. (Pubitemid 33152338)
32. Biniwale MA and Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 30: 200-208, 2006. (Pubitemid 44062678)
33. Blaisdell CJ, Gail DB, and Nabel EG. National Heart, Lung, and Blood Institute perspective: lung progenitor and stem cells-gaps in knowledge and future opportunities. Stem Cells 27: 2263-2270, 2009.
34. Bland RD, Albertine KH, Carlton DP, and MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172: 899-906, 2005. (Pubitemid 41369075)
35. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, and Dixit A. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 294: L3-L14, 2008. (Pubitemid 351380312)
36. Blau HM, Brazelton TR, and Weimann JM. The evolving concept of a stem cell: entity or function? Cell 105: 829-841, 2001. (Pubitemid 32635085)
37. Blum B and Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100: 133-158, 2008. (Pubitemid 351932182)
38. Bonnefont-Rousselot D and Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 278: 55-67, 2010.
39. Borghesi A, Massa M, Campanelli R, Bollani L, Tzialla C, Figar TA, Ferrari G, Bonetti E, Chiesa G, de Silvestri A, Spinillo A, Rosti V, and Stronati M. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 180: 540-546, 2009.
40. Borthwick DW, Shahbazian M, Krantz QT, Dorin JR, and Randell SH. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 24: 662-670, 2001. (Pubitemid 32550587)
41. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Tornell J, Heath JK, and Betsholtz C. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85: 863-873, 1996. (Pubitemid 26192137)
42. Bourbon J, Boucherat O, Chailley-Heu B, and Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57: 38R-46R, 2005. (Pubitemid 40593244)
43. Brettell LM and McGowan SE. Basic fibroblast growth factor decreases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol 10: 306-315, 1994.
44. Brion LP, Bell EF, and Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD003665, 2003.
45. Brody JS and Williams MC. Pulmonary alveolar epithelial cell differentiation. Annu Rev Physiol 54: 351-371, 1992.
46. Bry K, Hogmalm A, and Backstrom E. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin Perinatol 34: 211-221, 2010.
47. Buckley S, Shi W, Carraro G, Sedrakyan S, Da Sacco S, Driscoll BA, Perin L, de Filippo RE, and Warburton D. The milieu of damaged AEC2 stimulates alveolar wound repair by endogenous and exogenous progenitors. Am J Respir Cell Mol Biol 45: 1212-1221, 2011.
48. Buckley S and Warburton D. Dynamics of metalloproteinase-2 and-9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol Physiol 283: L747-754, 2002.
49. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, and Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 172: 854-860, 2005. (Pubitemid 41369069)
50. Burri PH. Structural aspect of prenatal and postnatal development and growth of the lung. In: Lung Growth and Development, edited by McDonald JA. New York: Marcel Dekker, 1997, pp. 1-35.
51. Capoluongo E, Ameglio F, and Zuppi C. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia. Clin Chem Lab Med 46: 1061-1066, 2008.
52. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala A, De Filippo RE, and Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26: 2902-2911, 2008.
53. Cerny L, Torday JS, and Rehan VK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 186: 75-89, 2008.
54. Chailley-Heu B, Boucherat O, Barlier-Mur A-M, and Bourbon Jr. FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts. Am J Physiol Lung Cell Mol Physiol 288: L43-L51, 2005. (Pubitemid 40023885)
55. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, Kang S, Jin HJ, Yang YS, and Park WS. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18: 869-886, 2009.
56. Chetty A, Andersson S, Lassus P, and Nielsen HC. Insulinlike growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol 37: 128-136, 2004. (Pubitemid 38120983)
57. Cho K-S, Park H-K, Park H-Y, Jung JS, Jeon S-G, Kim Y-K, and Roh HJ. IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 27: 259-265, 2009.
58. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, and Corazza GR. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60: 788-798, 2011.
59. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8: 73-81, 2003. (Pubitemid 36356495)
60. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179-184, 2006. (Pubitemid 44062675)
61. Coalson JJ, Winter VT, Siler-Khodr T, and Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333-1346, 1999. (Pubitemid 29487478)
62. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, and Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002. (Pubitemid 34778723)
63. Couroucli XI, Liang YW, Jiang W, Barrios R, and Moorthy B. Attenuation of oxygen-induced abnormal lung maturation in rats by retinoic acid: possible role of cytochrome P4501A enzymes. J Pharmacol Exp Ther 317: 946-954, 2006. (Pubitemid 43764096)
64. D'Angio CT and Maniscalco WM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci 7: d1609-d1623, 2002.
65. Daley GQ. Stem cells: roadmap to the clinic. J Clin Invest 120: 8-10, 2010.
66. Dammann CE, Nielsen HC, and Carraway KL, 3rd. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 167: 1711-1716, 2003. (Pubitemid 36760687)
67. Danan C, Jarreau P-H, Franco M-L, Dassieu G, Grillon C, Abd Alsamad I, Lafuma C, Harf A, and Delacourt C. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 283: L1086-L1093, 2002. (Pubitemid 35204901)
68. Darlow BA and Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev CD003312, 2003.
69. Davda J and Labhasetwar V. An update on angiogenesis therapy. Crit Rev Eukaryot Gene Expr 11: 1-21, 2001. (Pubitemid 32994857)
70. Davis JM and Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 15: 191-195, 2010.
71. Davis JM, Parad RB, Michele T, Allred E, Price A, and Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111: 469-476, 2003. (Pubitemid 36330700)
72. De Paepe ME, Mao Q, Ghanta S, Hovanesian V, and Padbury JF. Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. Am J Pathol 178: 1329-1339, 2011.
73. Debier C and Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr 93: 153-174, 2005.
74. Dobbs LG, Johnson MD, Vanderbilt J, Allen L, and Gonzalez R. The great big alveolar TI cell: evolving concepts and paradigms. Cell Physiol Biochem 25: 55-62, 2010.
75. Dovey JS, Zacharek SJ, Kim CF, and Lees JA. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci USA 105: 11857-11862, 2008.
76. Driscoll B, Buckley S, Bui KC, Anderson KD, and Warburton D. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol 279: L1191-L1198, 2000. (Pubitemid 32009505)
77. Dulak J and Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5: 123-132, 2003. (Pubitemid 36337023)
78. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL, and Truog WE. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113: 1709-1714, 2004. (Pubitemid 38697980)
79. Fadini GP, Avogaro A, and Agostini C. Pathophysiology of circulating progenitor cells in pulmonary disease and parallels with cardiovascular disease. Am J Respir Cell Mol Biol 35: 403-404, 2006. (Pubitemid 44353409)
80. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V, Thomas S, and Stocks J. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 182: 237-245, 2010.
81. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2: 33-46, 2001. (Pubitemid 34187905)
82. Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Remuzzi A, and Benigni A. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc 41: 1797-1800, 2009.
83. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID, 3rd, Buchter S, Sanchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Bhandari V, Watterberg KL, and Higgins RD. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362: 1970-1979, 2010.
84. Friedenstein AJ, Chailakhjan RK, and Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403, 1970.
85. Fritzell JA, Mao Q, Gundavarapu S, Pasquariello T, Aliotta JM, Ayala A, Padbury JF, and De Paepe ME. Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol 40: 575-587, 2009.
86. Gahrton G and Björkstrand B. Progress in haematopoietic stem cell transplantation for multiple myeloma. J Intern Med 248: 185-201, 2000.
87. Galambos C, Ng YS, Ali A, Noguchi A, Lovejoy S, D'Amore PA, and DeMello DE. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol 27: 194-203, 2002. (Pubitemid 34780799)
88. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, and Warburton D. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163: 2575-2584, 2003. (Pubitemid 37466498)
89. Giangreco A, Reynolds SD, and Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161: 173-182, 2002. (Pubitemid 34760783)
90. Gien J and Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 23: 305-313, 2011.
91. Gonzalez RF, Allen L, and Dobbs LG. Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro. Am J Physiol Lung Cell Mol Physiol 297: L1045-L1055, 2009.
92. Griffiths MJ, Bonnet D, and Janes SM. Stem cells of the alveolar epithelium. Lancet 366: 249-260, 2005. (Pubitemid 40981054)
93. Gupta N, Su X, Popov B, Lee JW, Serikov V, and Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863, 2007.
94. Hall SM, Hislop AA, Pierce CM, and Haworth SG. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. Am J Respir Cell Mol Biol 23: 194-203, 2000. (Pubitemid 30656429)
95. Han RN and Stewart DJ. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice. Trends Cardiovasc Med 16: 29-34, 2006. (Pubitemid 43012039)
96. Hansen AR, Barnes CM, Folkman J, and McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 156: 532-536, 2010.
97. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Jr., Reisman MA, Schaer GL, and Sherman W. A randomized, double-blind, placebocontrolled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54: 2277-2286, 2009.
98. Hato T, Kimura Y, Morisada T, Koh GY, Miyata K, Tabata M, Kadomatsu T, Endo M, Urano T, Arai F, Araki K, Suda T, Kobayashi K, and Oike Y. Angiopoietins contribute to lung development by regulating pulmonary vascular network formation. Biochem Biophys Res Commun 381: 218-223, 2009.
99. Hay WW, Jr. and Bell EF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics 105: 424-425, 2000. (Pubitemid 30078689)
100. Hegab AE, Kubo H, Fujino N, Suzuki T, He M, Kato H, and Yamaya M. Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev 19: 523-536, 2010.
101. Hegeman MA, Hennus MP, van Meurs M, Cobelens PM, Kavelaars A, Jansen NJ, Schultz MJ, van Vught AJ, Molema G, and Heijnen CJ. Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury. PLoS One 5: e15653, 2010.
102. Helmy KY, Patel SA, Silverio K, Pliner L, and Rameshwar P. Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv 1: 693-705, 2010.
103. Herzog EL, Chai L, and Krause DS. Plasticity of marrowderived stem cells. Blood 102: 3483-3493, 2003.
104. Hilgendorff A, Parai K, Ertsey R, Jain N, Navarro EF, Peterson JL, Tamosiuniene R, Nicolls MR, Starcher BC, Rabinovitch M, and Bland RD. Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice. Am J Respir Crit Care Med 184: 537-546, 2011.
105. Hong KU, Reynolds SD, Giangreco A, Hurley CM, and Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 24: 671-681, 2001. (Pubitemid 32550588)
106. Hong KU, Reynolds SD, Watkins S, Fuchs E, and Stripp BR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 164: 577-588, 2004. (Pubitemid 38364673)
107. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, and Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313, 1999. (Pubitemid 29124367)
108. Ionescu LI, Alphonse RS, Arizmendi N, Morgan B, Abel M, Eaton F, Duszyk M, Vliagoftis H, Aprahamian TR, Walsh K, and Thebaud B. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 46: 207-216, 2012.
109. Irwin D, Helm K, Campbell N, Imamura M, Fagan K, Harral J, Carr M, Young KA, Klemm D, Gebb S, Dempsey EC, West J, and Majka S. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification. Am J Physiol Lung Cell Mol Physiol 293: L941-L951, 2007. (Pubitemid 47572242)
110. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Suzuki T, Mizuno S, Nakamura T, and Sasaki H. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 324: 276-280, 2004. (Pubitemid 39311490)
111. Iyer SS, Torres-Gonzalez E, Neujahr DC, Kwon M, Brigham KL, Jones DP, Mora AL, and Rojas M. Effect of bone marrow-derived mesenchymal stem cells on endotoxininduced oxidation of plasma cysteine and glutathione in mice. Stem Cells Int 2010: 868076, 2010.
112. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
113. James ML, Ross AC, Bulger A, Philips JB, 3rd, and Ambalavanan N. Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice. Pediatr Res 67: 591-597, 2010.
114. Janer J, Andersson S, Haglund C, and Lassus P. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Pediatrics 119: e241-e246, 2007. (Pubitemid 46397831)
115. Janer J, Andersson S, Kajantie E, and Lassus P. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants. Pediatrics 123: 1142-1146, 2009.
116. Jankov RP, Negus A, and Tanswell AK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50: 681-687, 2001. (Pubitemid 33121635)
117. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, and Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49, 2002. (Pubitemid 34742565)
118. Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 8: 9-17, 2003. (Pubitemid 36356489)
119. Josko J and Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 10: RA89-RA98, 2004. (Pubitemid 38525095)
120. Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, Matsuda A, Arranto C, Goichberg P, Giordano G, Haley KJ, Bardelli S, Rayatzadeh H, Liu X, Quaini F, Liao R, Leri A, Perrella MA, Loscalzo J, and Anversa P. Evidence for human lung stem cells. N Engl J Med 364: 1795-1806, 2011.
121. Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, and Katsumata T. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114: I181-I185, 2006. (Pubitemid 44297148)
122. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, and Saijo Y. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther J Am Soc Gene Ther 19: 196-203, 2011.
123. Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, and Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10: 657-667, 2008.
124. Kim CB. Advancing the field of lung stem cell biology. Front Biosci 12: 3117-3124, 2007.
125. Kim CFB, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835, 2005. (Pubitemid 40806415)
126. Kim DH, Choi CW, Kim EK, Kim HS, Kim BI, Choi JH, Lee MJ, and Yang EG. Association of increased pulmonary interleukin-6 with the priming effect of intra-amniotic lipopolysaccharide on hyperoxic lung injury in a rat model of bronchopulmonary dysplasia. Neonatology 98: 23-32, 2010.
127. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, and Abman SH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355: 354-364, 2006. (Pubitemid 44127538)
128. Kinsella JP, Greenough A, and Abman SH. Bronchopulmonary dysplasia. Lancet 367: 1421-1431, 2006.
129. Koo HC, Davis JM, Li Y, Hatzis D, Opsimos H, Pollack S, Strayer MS, Ballard PL, and Kazzaz JA. Effects of transgene expression of superoxide dismutase and glutathione peroxidase on pulmonary epithelial cell growth in hyperoxia. Am J Physiol Lung Cell Mol Physiol 288: L718-L726, 2005. (Pubitemid 40404140)
130. Kotecha S, Wangoo A, Silverman M, and Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 128: 464-469, 1996. (Pubitemid 26114082)
131. Kovacic JC and Boehm M. Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology. Stem Cell Res 2: 2-15, 2009.
132. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, and Matthay MA. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 28: 2229-2238, 2010.
133. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, and Sharkis SJ. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377, 2001. (Pubitemid 32455343)
134. Kugathasan L, Ray JB, Deng Y, Rezaei E, Dumont DJ, and Stewart DJ. The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 206: 2221-2234, 2009.
135. Kumamoto M, Nishiwaki T, Matsuo N, Kimura H, and Matsushima K. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34: 740-748, 2009.
136. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, and Abman SH. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289: L529-L535, 2005. (Pubitemid 41361662)
137. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, and Thebaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172: 750-756, 2005. (Pubitemid 41324231)
138. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, and Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441, 2004. (Pubitemid 38586721)
139. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
140. Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, and Akeson AL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space
141. Lee HJ, Choi CW, Kim BI, Kim EK, Kim HS, Choi JH, Lee MJ, and Yang EG. Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia. J Perinat Med 38: 675-681, 2010.
142. Lee JW, Gupta N, Serikov V, and Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 9: 1259-1270, 2009.
143. Leuwerke SM, Kaza AK, Tribble CG, Kron IL, and Laubach VE. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol 282: L1272-L1278, 2002. (Pubitemid 34654583)
144. Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, and Weiss DJ. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol 38: 16-25, 2008.
145. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, and Keating MT. Elastin is an essential determinant of arterialmorphogenesis. Nature 393: 276-280, 1998.
146. Liebler JM, Lutzko C, Banfalvi A, Senadheera D, Aghamohammadi N, Crandall ED, and Borok Z. Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 295: L285-L292, 2008.
147. Lin Y and Hogan WJ. Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versushost disease. Adv Hematol 2011: 427863, 2011.
148. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22-29, 2005. (Pubitemid 40967424)
149. Lindahl P, Karlsson L, Hellström M, Gebre-Medhin S, Willetts K, Heath JK, and Betsholtz C. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 124: 3943-3953, 1997. (Pubitemid 27483322)
150. Ling T-Y, Kuo M-D, Li C-L, Yu AL, Huang Y-H, Wu T-J, Lin Y-C, Chen S-H, and Yu J. Identification of pulmonary Oct-4 + stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci USA 103: 9530-9535, 2006. (Pubitemid 43955859)
151. Liu C, Morrisey EE, and Whitsett JA. GATA-6 is required for maturation of the lung in late gestation. Am J Physiol Lung Cell Mol Physiol 283: L468-L475, 2002. (Pubitemid 34804005)
152. Liu H, Chang L, Rong Z, Zhu H, Zhang Q, Chen H, and Li W. Association of insulin-like growth factors with lung development in neonatal rats. J Huazhong Univ Sci Technol Med Sci 24: 162-165, 2004. (Pubitemid 41559661)
153. Loi R, Beckett T, Goncz KK, Suratt BT, and Weiss DJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 173: 171-179, 2006. (Pubitemid 43187889)
154. Luo X, Sedlackova L, Belcastro R, Cabacungan J, Lye SJ, and Tanswell AK. Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats. Pediatr Res 46: 215-223, 1999. (Pubitemid 29362737)
155. Majka SM, Beutz MA, Hagen M, Izzo AA, Voelkel N, and Helm KM. Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells 23: 1073-1081, 2005. (Pubitemid 41377723)
156. Malgieri A, Kantzari E, PatriziMP, and Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin ExpMed 3: 248-269, 2010.
157. Maniscalco WM, Watkins RH, Roper JM, Staversky R, and O'Reilly MA. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res 58: 549-556, 2005. (Pubitemid 41254523)
158. Mason RJ. Biology of alveolar type II cells. Respirology 11 Suppl: S12-S15, 2006.
159. Masood A, Yi M, Lau M, Belcastro R, Shek S, Pan J, Kantores C, McNamara PJ, Kavanagh BP, Belik J, Jankov RP, and Tanswell AK. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am J Physiol Lung Cell Mol Physiol 297: L920-L930, 2009.
160. Matthay MA, Thompson BT, Read EJ, McKenna DH, Liu KD, Calfee CS, and Lee JW. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138: 965-972, 2010.
161. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RN, Dumont DJ, and Stewart DJ. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 175: 1014-1026, 2007. (Pubitemid 46741753)
162. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, and Shaul PW. In-haled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288: L450-L459, 2005. (Pubitemid 40229510)
163. McGrath-Morrow SA, Cho C, Zhen L, Hicklin DJ, and Tuder RM. Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development. Am J Respir Cell Mol Biol 32: 420-427, 2005. (Pubitemid 40629327)
164. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, and Bertoncello I. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 27: 623-633, 2009.
165. McQualter JL, Yuen K, Williams B, and Bertoncello I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 107: 1414-1419, 2010.
166. Mei SHJ, McCarter SD, Deng Y, Parker CH, Liles WC, and Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4: e269, 2007.
167. Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, and Baldassarre J. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet 376: 346-354, 2010.
168. Metzger RJ, Klein OD, Martin GR, and Krasnow MA. The branching programme of mouse lung development. Nature 453: 745-750, 2008. (Pubitemid 351793786)
169. Metzger RJ and Krasnow MA. Genetic control of branching morphogenesis. Science 284: 1635-1639, 1999. (Pubitemid 29291366)
170. Moodley Y, Atienza D,Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, and Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycininduced lung injury. Am J Pathol 175: 303-313, 2009.
171. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, and Toews GB. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684, 2005. (Pubitemid 40315625)
172. Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, and Spagnoli A. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther 10: 1663-1679, 2010.
173. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Gorham JD, Bundoc VG, Bundoc VG, Hodges MG, Jelinek I, Madala S, Karpati S, and Mezey E. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107: 5652-5657, 2010.
174. Németh K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, and Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49, 2009.
175. Neuringer IP and Randell SH. Stem cells and repair of lung injuries. Respir Res 5: 6, 2004.
176. Nielsen HC. Epidermal growth factor influences the developmental clock regulating maturation of the fetal lung fibroblast. Biochim Biophys Acta 1012: 201-206, 1989. (Pubitemid 19181754)
177. Nolen-Walston RD, Kim CF, Mazan MR, Ingenito EP, Gruntman AM, Tsai L, Boston R, Woolfenden AE, Jacks T, and Hoffman AM. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol 294: L1158-L1165, 2008.
178. Northway WH, Jr., Rosan RC, and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
179. Ohki Y, Mayuzumi H, Tokuyama K, Yoshizawa Y, Arakawa H, Mochizuki H, and Morikawa A. Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia. Neonatology 95: 332-338, 2009.
180. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, and Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007, 2007. (Pubitemid 47175216)
181. Pan L, Fu JH, Xue XD, Xu W, Zhou P, and Wei B. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonarydysplasia.World J Pediatr 5: 216-221, 2009.
182. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997. (Pubitemid 28022851)
183. Park H-K, Cho K-S, Park H-Y, Shin DH, Kim Y-K, Jung JS, Park SK, and Roh HJ. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 19: 1811-1818, 2010.
184. Pasquali MA, Gelain DP, Oliveira MR, Behr GA, Motta LL, Rocha RF, Klamt F, and Moreira JC. Vitamin A supplementation induces oxidative stress and decreases the immunocontent of catalase and superoxide dismutase in rat lungs. Exp Lung Res 35: 427-438, 2009.
185. Perrone S, Tataranno ML, Negro S, Longini M, Marzocchi B, Proietti F, Iacoponi F, Capitani S, and Buonocore G. Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev 86: 241-244, 2010.
186. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, and Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446, 2004. (Pubitemid 39071616)
187. Pierce RA, Albertine KH, Starcher BC, Bohnsack JF, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol 272: L452-L460, 1997.
188. Pierro M and Thebaud B. Mesenchymal stem cells in chronic lung disease: culprit or savior? Am J Physiol Lung Cell Mol Physiol 298: L732-L734, 2010.
189. Popova AP, Bozyk PD, Bentley JK, Linn MJ, Goldsmith AM, Schumacher RE, Weiner GM, Filbrun AG, and Hershenson MB. Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia. Pediatrics 126: e1127-e1133, 2010.
190. Popova AP, Bozyk PD, Goldsmith AM, Linn MJ, Lei J, Bentley JK, and Hershenson MB. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 298: L735-L743, 2010.
191. Powers HJ, Loban A, Silvers K, and Gibson AT. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Radic Res 22: 57-65, 1995.
192. Prater DN, Case J, Ingram DA, and Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia 21: 1141-1149, 2007. (Pubitemid 46831802)
193. Purevdorj E, Zscheppang K, Hoymann HG, Braun A, von Mayersbach D, Brinkhaus MJ, Schmiedl A, and Dammann CE. ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 294: L516-L522, 2008. (Pubitemid 351468851)
194. Quintos-Alagheband ML, White CW, and Schwarz MA. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia. Antioxid Redox Signal 6: 137-145, 2004. (Pubitemid 38063985)
195. Ramirez MI, Millien G, Hinds A, Cao Y, Seldin DC, and Williams MC. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol 256: 61-72, 2003. (Pubitemid 36332205)
196. Ramsay PL, DeMayo FJ, Hegemier SE, Wearden ME, Smith CV, and Welty SE. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 155-161, 2001. (Pubitemid 33151313)
197. Raoul W, Wagner-Ballon O, Saber G, Hulin A, Marcos E, Giraudier S, Vainchenker W, Adnot S, Eddahibi S, and Maitre B. Effects of bone marrow-derived cells on monocrotaline-and hypoxia-induced pulmonary hypertension in mice. Respir Res 8: 8, 2007.
198. Rawlins EL, Clark CP, Xue Y, and Hogan BLM. The Id2 + distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136: 3741-3745, 2009.
199. Rawlins EL and Hogan BLM. Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133: 2455-2465, 2006. (Pubitemid 44123396)
200. Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H, Wang F, and Hogan BLM. The role of Scgb1a1 + Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4: 525-534, 2009.
201. Reddy R, Buckley S, Doerken M, Barsky L, Weinberg K, Anderson KD, Warburton D, and Driscoll B. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol 286: L658-L667, 2004. (Pubitemid 38365048)
202. Reynolds SD, Shen H, Reynolds PR, Betsuyaku T, Pilewski JM, Gambelli F, Di Giuseppe M, Ortiz LA, and Stripp BR. Molecular and functional properties of lung SP cells. Am J Physiol Lung Cell Mol Physiol 292: L972-L983, 2007. (Pubitemid 46608244)
203. Ribatti D. Endogenous inhibitors of angiogenesis: a historical review. Leuk Res 33: 638-644, 2009.
204. Rock JR, Randell SH, and Hogan BLM. Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech 3: 545-556, 2010.
205. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, and Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152, 2005. (Pubitemid 41473051)
206. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, and Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126: 605-610, 1995.
207. Roth-Kleiner M and Post M. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol 40: 113-134, 2005. (Pubitemid 41099428)
208. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, and HoekstraWG. Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
209. Saugstad OD. Optimal oxygenation at birth and in the neonatal period. Neonatology 91: 319-322, 2007. (Pubitemid 46934218)
210. Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 38: 571-577, 2010.
211. Schipani E and Kronenberg HM. Adult mesenchymal stem cells. In: StemBook. Cambridge, MA: Harvard Stem Cell Institute, 2008. Available at www.ncbi.nlm.nih.gov/pubmed/20614616 cited 2012 Mar 30.
212. Schmiedl A, Behrens J, Zscheppang K, Purevdorj E, von Mayersbach D, Liese A, and Dammann CE. Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs. Am J Physiol Lung Cell Mol Physiol 301: L490-L499, 2011.
213. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, and Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349: 2099-2107, 2003. (Pubitemid 37464534)
214. Schultz CJ, Torres E, Londos C, and Torday JS. Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells. Am J Physiol Lung Cell Mol Physiol 283: L288-L296, 2002. (Pubitemid 34803984)
215. Schwarz M, Lee M, Zhang F, Zhao J, Jin Y, Smith S, Bhuva J, Stern D, Warburton D, and Starnes V. EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol 276: L365-L375, 1999. (Pubitemid 29102279)
216. SessaWC. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost 7 Suppl 1: 35-37, 2009.
217. Shi W, Xu J and Warburton D. Development, repair and fibrosis: what is common and why it matters. Respirology 14: 656-665, 2009.
218. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Matsuyama A, Shiono H, Nakamura T, and Sawa Y. Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med 174: 1199-1205, 2006. (Pubitemid 44924820)
219. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Nakamura T, and Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant 6: 2592-2600, 2006. (Pubitemid 44571679)
220. Snyder JC, Teisanu RM, and Stripp BR. Endogenous lung stem cells and contribution to disease. J Pathol 217: 254-264, 2009.
221. Stahl W and Sies H. Antioxidant defense: vitamins E and C and carotenoids. Diabetes 46 Suppl 2: S14-S18, 1997. (Pubitemid 27377392)
222. Stenmark KR and Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 67: 623-661, 2005. (Pubitemid 40404504)
223. Stenson B, Brocklehurst P, and Tarnow-Mordi W. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med 364: 1680-1682, 2011.
224. Stevenson K, McGlynn L, and Shiels PG. Stem cells: outstanding potential and outstanding questions. Scott Med J 54: 35-37, 2009.
225. Stone KC, Mercer RR, Gehr P, Stockstill B, and Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 6: 235-243, 1992.
226. Stripp BR. Hierarchical organization of lung progenitor cells: is there an adult lung tissue stem cell? Proc Am Thorac Soc 5: 695-698, 2008.
227. Sueblinvong V and Weiss DJ. Stem cells and cell therapy approaches in lung biology and diseases. Transl Res 156: 188-205, 2010.
228. Summer R, Kotton DN, Sun X, Ma B, Fitzsimmons K, and Fine A. Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol 285: L97-L104, 2003. (Pubitemid 36736472)
229. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006. (Pubitemid 44233629)
230. Takahashi M, Nakamura T, Toba T, Kajiwara N, Kato H, and Shimizu Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 10: 771-779, 2004. (Pubitemid 38880395)
231. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287: L344-L351, 2004. (Pubitemid 38943916)
232. ter Horst SA, Fijlstra M, Sengupta S, Walther FJ, and Wagenaar GT. Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury. BMC Pulm Med 6: 8, 2006.
233. Thebaud B and Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175: 978-985, 2007. (Pubitemid 46741748)
234. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, and Archer SL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477-2486, 2005. (Pubitemid 41504498)
235. Thomas M and Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12: 125-137, 2009.
236. Thomas W, Seidenspinner S, Kramer BW, Kawczynska-Leda N, Chmielnicka-Kopaczyk M, Marx A, Wirbelauer J, Szymankiewicz M, and Speer CP. Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/death. Pediatr Res 65: 468-473, 2009.
237. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200: 575-580, 2002. (Pubitemid 34823049)
238. Till JE and Mcculloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213-222, 1961.
239. Tin W. Optimal oxygen saturation for preterm babies. Do we really know? Biol Neonate 85: 319-325, 2004. (Pubitemid 38813011)
240. Tö gel F, Hu Z, Weiss K, Isaac J, Lange C, and Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiationindependent mechanisms. Am J Physiol Renal Physiol 289: F31-F42, 2005. (Pubitemid 40863570)
241. Torday JS and Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 62: 2-7, 2007. (Pubitemid 46985841)
242. Tourneux P, Markham N, Seedorf G, Balasubramaniam V, and Abman SH. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycininduced bronchopulmonary dysplasia in neonatal rats. Am J Physiol Lung Cell Mol Physiol 297: L1103-L1111, 2009.
243. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, and Fanaroff AA. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340: 1962-1968, 1999.
244. Ulich TR, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, Housley RM, and Pierce GF. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 93: 1298-1306, 1994. (Pubitemid 24087188)
245. Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani EH, Wagenaar GTM, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, and van der Laarse A. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 297: H1606-H1616, 2009.
246. van der Heijden M, van Nieuw Amerongen GP, Chedamni S, van Hinsbergh VW, and Johan Groeneveld AB. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin Ther Targets 13: 39-53, 2009.
247. van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, and Thébaud B. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180: 1131-1142, 2009.
248. Vats A, Bielby RC, Tolley NS, Nerem R, and Polak JM. Stem cells. Lancet 366: 592-602, 2005. (Pubitemid 41149084)
249. Veness-Meehan KA, Bottone FG, Jr., and Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res 48: 434-444, 2000.
250. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, and Elias JA. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31: 650-656, 2004. (Pubitemid 39587495)
251. Vosdoganes P, Hodges RJ, Lim R, Westover AJ, Acharya RY, Wallace EM, and Moss TJ. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol 205: 156 e26-156 e33, 2011.
252. Vozzelli MA, Mason SN, Whorton MH, and Auten RL, Jr. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 286: L488-L493, 2004. (Pubitemid 38233618)
253. Wagenaar GT, ter Horst SA, van Gastelen MA, Leijser LM, Mauad T, van der Velden PA, de Heer E, Hiemstra PS, Poorthuis BJ, and Walther FJ. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med 36: 782-801, 2004. (Pubitemid 38264421)
254. Wan H, Xu Y, Ikegami M, Stahlman MT, Kaestner KH, Ang S-L, and Whitsett JA. Foxa2 is required for transition to air breathing at birth. Proc Natl Acad Sci USA 101: 14449-14454, 2004. (Pubitemid 39346769)
255. Wang D, Morales JE, Calame DG, Alcorn JL, and Wetsel RA. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 18: 625-634, 2010.
256. Watt FM and Hogan BL. Out of Eden: stem cells and their niches. Science 287: 1427-1430, 2000. (Pubitemid 30127126)
257. Wendel DP, Taylor DG, Albertine KH, Keating MT, and Li DY. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol 23: 320-326, 2000.
258. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, and Chambers DC. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 32: 321-328, 2008.
259. Xu J, Qu J, Cao L, Sai Y, Chen C, He L, and Yu L. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214: 472-481, 2008. (Pubitemid 351340567)
260. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, and Rojas M. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293: L131-L141, 2007. (Pubitemid 47080721)
261. Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW, Tompkins RG, and Yarmush ML. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 19: 823-830, 2010.
262. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, and Yarmush ML. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864, 2010.
263. Yamada M, Kubo H, Ishizawa K, Kobayashi S, Shinkawa M, and Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 60: 410-413, 2005. (Pubitemid 40685824)
264. Young SL, Evans K, and Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 282: L379-L385, 2002. (Pubitemid 34654639)
265. Zaret KS and Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 322: 1490-1494, 2008.
266. Zhao T, Zhang ZN, Rong Z, and Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215, 2011.
267. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, and Stewart DJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450, 2005. (Pubitemid 40354538)
268. Zhen G, Liu H, Gu N, Zhang H, Xu Y, and Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 13: 3415-3422, 2008. (Pubitemid 351594692)